Tenax Therapeutics Revenue, Growth & Competitor Profile

DBA OXYGEN BIOTHERAPEUTICS, INC.

Company Profile & Annual Report for Tenax Therapeutics

Access the complete profile.

Tenax Therapeutics Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	1 - 10Exact Company Size
Primary Industry	4242 Drugs & Druggists' Sundries Merchant Wholesalers
Additional NAICS Codes	541711 Research & Development in Biotechnology
Address	101 Glen Lennox Drive Suite 300 Chapel Hill, NC 27517

Note: Revenues for privately held companies are statistical evaluations.


Tenax Therapeutics's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Tenax Therapeutics's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Tenax Therapeutics is classified as operating in the Drugs & Druggists' Sundries Merchant Wholesalers industry, NAICS Code 4242.

Tenax Therapeutics Annual Revenue and Growth Rate

Tenax Therapeutics	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$10 - $100 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Tenax Therapeutics's revenues are gauged from an analysis of company filings.

Tenax Therapeutics's Income Statement (based on Industry Averages)

Tenax Therapeutics P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Tenax Therapeutics is developing and marketing. Tenax Therapeutics doesn't have any recent trademark applications, indicating Tenax Therapeutics is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
TENAX THERAPEUTICS Pharmaceutical preparations for the treatment of traumatic brain injury, lung disorders, respiratory failure, heart failure, stroke, low cardiac output syndrome, septic shock, traumatic brain injury, kidney failure, acute critical care conditions, tissue ischemia, burns, wounds, sickle cell disease, acne and dandruff; Pharmaceutical preparations for improving muscle contraction; Pharmaceutical preparations for increasing inotropic state; Pharmaceutical preparations for improving dilation of blood vessels	10/01/2018
DERMACYTE Pharmaceutical preparations for use in dermatology and cosmetology	04/30/2009
OXYCYTE Pharmaceutical preparations for the treatment of tissue ischemia, burns, wounds, traumatic brain injury, lung disorders, sickle cell disease, and hair conditions, namely, dandruff	12/08/2008

See all trademarks and details in the Full Report.

Market Share of Tenax Therapeutics's Largest Competitors

A competitive analysis shows these companies are in the same general field as Tenax Therapeutics, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
AMERISOURCEBERGEN	Conshohocken, PA	100
MCKESSON	Irving, TX	58
CARDINAL HEALTH 119	Dublin, OH	42
TAKEDA PHARMACEUTICALS AMERICA	Lexington, MA	31
CATALENT PHARMA SOLUTIONS	Somerset, NJ	13
OWENS & MINOR DISTRIBUTION	Mechanicsville, VA	11
J M SMITH	Spartanburg, SC	3
DAIICHI SANKYO	Basking Ridge, NJ	3
HIKMA PHARMACEUTICALS USA	Berkeley Heights, NJ	2

Nearby Competitors

These companies are similar in business line and location to Tenax Therapeutics. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
CHIESI USA	Cary, NC	100
WE PHARMA	Morrisville, NC	13
WE PHARMA DBA WEP CLINICAL	Morrisville, NC	4
TENAX THERAPEUTICS	Chapel Hill, NC	2
UNITED DRUG SUPPLY	Morrisville, NC	1
WAKE FOREST DRUG	Wake Forest, NC	0

Future Competition: Tenax Therapeutics's Fastest Growing Competitors

These companies are in the same general field as Tenax Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)